Skystar Bio-Pharmaceutical Co (FRA:GNJC) Other Operating Expense : €0.00 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Other Operating Expense?

Skystar Bio-Pharmaceutical Co's Other Operating Expense for the three months ended in Sep. 2014 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2014 was €0.00 Mil.

Skystar Bio-Pharmaceutical Co's quarterly Other Operating Expense declined from Mar. 2014 (€0.00 Mil) to Jun. 2014 (€-0.00 Mil) but then increased from Jun. 2014 (€-0.00 Mil) to Sep. 2014 (€0.00 Mil).

Skystar Bio-Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2011 (€0.00 Mil) to Dec. 2012 (€-0.00 Mil) but then increased from Dec. 2012 (€-0.00 Mil) to Dec. 2013 (€0.00 Mil).

Skystar Bio-Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Other Operating Expense Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Other Operating Expense

Get a 7-Day Free Trial

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Skystar Bio-Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Skystar Bio-Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines